REVIVA PHARMACEUTICALS HOLDINGS, INC.

Reviva Pharmaceuticals Holdings, Inc., trading under the ticker TZAC, is a clinical-stage biopharmaceutical company that completed a business combination with Tenzing Acquisition Corp, a blank-check company that conducted its IPO in 2020. The October 2020 Form 8-K filing, bearing accession number 0001104659-20-117007, reflects activity surrounding that SPAC transaction. Reviva focuses on developing novel therapeutics for neuropsychiatric and metabolic disorders, including treatments targeting schizophrenia and Parkinson's disease, placing it squarely within the healthcare and life sciences sector. The combined company operates in the clinical-stage biopharma space with a pipeline oriented around central nervous system conditions. Sign up for full data on SpacDesk to access complete filing histories, sponsor profiles, and deal analytics for this and every active SPAC.